LifeStance Health Group jumped 20% on May 7. The options market reacted immediately — and the signal is hard to miss.
The put/call ratio hit 0.0707 on earnings day. That's 3.5 standard deviations above the 20-day mean of 0.0183. It marks the most extreme call-buying episode in recent history for this stock. Traders rushed to capture upside following the earnings print, pushing call volume far ahead of puts.
A PCR z-score of 3.5 is statistically unusual. The 20-day mean PCR was just 0.0183 — meaning for every put traded, there were roughly 55 calls. On May 7, that ratio compressed sharply to one put for every 14 calls. The 52-week low PCR is 0.0052, so the market has seen even more extreme call dominance before. But the sudden one-day spike from a stable baseline is what stands out here.
The stock is up 38% over the past month and 17% on the week heading into this reading.
SI stood at 2.41% of free float as of May 6 — 9.4 million shares short. That's not a large short position in absolute terms. But it grew 47% in a week ahead of earnings. Short sellers added aggressively into the print, and the stock moved sharply against them.
Cost to borrow remains low at 0.44%. Availability is ample. There's no borrow squeeze here. The lending market is not the story — the positioning error is.
Multiple firms raised price targets in recent months. UBS holds a Buy with a $12 target. BTIG has a Buy at $11. Canaccord Genuity sits at $10. The consensus mean target is $10.06, still above the current price of $8.85 despite the recent rally.
Institutional holders tell a similar story. BlackRock added 11.9 million shares in its latest reported period. FMR (Fidelity) added 7.8 million. State Street added 1.8 million. The largest holder, TPG Capital at 36% of shares, trimmed its position by 20.7 million shares — but remains dominant.
The ORTEX short score sits at 39.6, mid-range. EPS momentum scores are strong: 69th percentile over 30 days, 92nd percentile over 90 days. The earnings trajectory was visible in the data before the print.
What to watch: Whether the PCR normalises back toward its 0.018 baseline over the next few sessions, or whether call demand persists — that will indicate whether the post-earnings move is drawing sustained new interest or a one-day reaction.
See the live data behind this article on ORTEX.
Open LFST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
